Patients with aggressive type of breast cancer can look forward to cheaper medicines

  • Nation
  • Monday, 10 Dec 2018

PETALING JAYA: Good news for patients who could not afford an exorbitant medicine for an aggressive type of breast cancer.

The Health Ministry has approved the biosimilar version of trastuzumab (a monoclonal antibody), a targeted therapy, for women with HER2-positive breast cancer patients, said Dr Dzulkefly Ahmad.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Nation

Zayn Rayyan murder: Autopsy shows victim possibly struggled with murderer, says cops
There are still many Malaysians falling victim to job scams, says Fadillah
Floods: 1,581 still housed at six relief centres in Pasir Mas
Two policemen among four detained for robbing foreign workers
Priority on resolving basic issues, not building Labuan-Sabah bridge, says PM
Three kids drown in Kudat construction pool
No new Covid-19 variants in Malaysia, says Dr Zaliha
My daughter keeps asking for Daddy, says Syed Muhammad Danial's widow
Freeze on foreign workers' quota still active, says Sivakumar
Multiracial 2,000-singer gathering in Kuching sets Christmas carol record

Others Also Read